These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 9931648)

  • 1. [What is the value of recent molecular biology knowledge for surgical oncologic therapy of soft tissue sarcoma?].
    Willeke F
    Langenbecks Arch Chir Suppl Kongressbd; 1998; 115():393-8. PubMed ID: 9931648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Detection of chromosomal abnormalities in soft tissue sarcomas: which sarcomas? Which abnormalities? How? Why?].
    Genevay M; Gengler C; Guillou L
    Bull Cancer; 2007 Sep; 94(9):781-92. PubMed ID: 17878098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aberrant expression of cell-cycle regulatory proteins in human mesenchymal neoplasia.
    Creager AJ; Cohen JA; Geradts J
    Cancer Detect Prev; 2001; 25(2):123-31. PubMed ID: 11341347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic analysis of childhood sarcoma.
    Strong LC; Williams WR; Ferrell RE; Tainsky MA
    Princess Takamatsu Symp; 1989; 20():151-7. PubMed ID: 2488230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Soft tissue sarcomas: update on molecular data].
    Bui Nguyen Binh M; Collin F; Coindre JM
    Cancer Radiother; 2006; 10(1-2):15-21. PubMed ID: 16442827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immunologic presentation of P53 protein in cell nucleus of soft tissue sarcoma].
    Budach V
    Strahlenther Onkol; 1995 Jan; 171(1):55-6. PubMed ID: 7839308
    [No Abstract]   [Full Text] [Related]  

  • 7. Tumor suppressor genes and related molecules in leiomyosarcoma.
    Dei Tos AP; Maestro R; Doglioni C; Piccinin S; Libera DD; Boiocchi M; Fletcher CD
    Am J Pathol; 1996 Apr; 148(4):1037-45. PubMed ID: 8644845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. H-ras and K-ras mutations in soft tissue sarcoma: comparative studies of sarcomas from Korean and American patients.
    Yoo J; Robinson RA
    Cancer; 1999 Jul; 86(1):58-63. PubMed ID: 10391564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of genetic testing in soft tissue sarcoma.
    Antonescu CR
    Histopathology; 2006 Jan; 48(1):13-21. PubMed ID: 16359533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequent loss of expression or aberrant alternative splicing of P2XM, a p53-inducible gene, in soft-tissue tumours.
    Nawa G; Miyoshi Y; Yoshikawa H; Ochi T; Nakamura Y
    Br J Cancer; 1999 Jun; 80(8):1185-9. PubMed ID: 10376970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytogenetics and molecular biology of soft tissue tumors.
    Fletcher JA
    Monogr Pathol; 1996; 38():37-64. PubMed ID: 8744274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular pathology and potential therapeutic targets in soft-tissue sarcoma.
    Todd R; Lunec J
    Expert Rev Anticancer Ther; 2008 Jun; 8(6):939-48. PubMed ID: 18533803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sarcomas: genetics, signalling, and cellular origins. Part 1: The fellowship of TET.
    Riggi N; Cironi L; Suvà ML; Stamenkovic I
    J Pathol; 2007 Sep; 213(1):4-20. PubMed ID: 17691072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of various exon combinations of the ews/fli1 translocation: an optimized RT-PCR method for paraffin embedded tissue -- a report by the CWS-study group.
    Stegmaier S; Leuschner I; Aakcha-Rudel E; Münch P; Kazanowska B; Bekassy A; Treuner J; Koscielniak E
    Klin Padiatr; 2004; 216(6):315-22. PubMed ID: 15565546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The clinical relevance of molecular genetics in soft tissue sarcomas.
    Ordóñez JL; Osuna D; García-Domínguez DJ; Amaral AT; Otero-Motta AP; Mackintosh C; Sevillano MV; Barbado MV; Hernández T; de Alava E
    Adv Anat Pathol; 2010 May; 17(3):162-81. PubMed ID: 20418671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Telomerase activity and human telomerase reverse transcriptase mRNA expression are correlated with clinical aggressiveness in soft tissue tumors.
    Tomoda R; Seto M; Tsumuki H; Iida K; Yamazaki T; Sonoda J; Matsumine A; Uchida A
    Cancer; 2002 Sep; 95(5):1127-33. PubMed ID: 12209700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p53 missense but not truncation mutations are associated with low levels of p21(CIP1/WAF1) mRNA expression in primary human sarcomas.
    Mousses S; Gokgoz N; Wunder JS; Ozcelik H; Bull S; Bell RS; Andrulis IL
    Br J Cancer; 2001 Jun; 84(12):1635-9. PubMed ID: 11401317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlations of telomere length, P53 mutation, and chromosomal translocation in soft tissue sarcomas.
    Liu C; Li B; Li L; Zhang H; Chen Y; Cui X; Hu J; Jiang J; Qi Y; Li F
    Int J Clin Exp Pathol; 2015; 8(5):5666-73. PubMed ID: 26191279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression profiling of t(12;22) positive clear cell sarcoma of soft tissue cell lines reveals characteristic up-regulation of potential new marker genes including ERBB3.
    Schaefer KL; Brachwitz K; Wai DH; Braun Y; Diallo R; Korsching E; Eisenacher M; Voss R; Van Valen F; Baer C; Selle B; Spahn L; Liao SK; Lee KA; Hogendoorn PC; Reifenberger G; Gabbert HE; Poremba C
    Cancer Res; 2004 May; 64(10):3395-405. PubMed ID: 15150091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Chromosomal translocations in soft tissue sarcomas: from molecular biology to clinical application].
    Roma J; Masià A; Almazán-Moga A; Rebull M; Velasco P; Gallego S; Sánchez de Toledo J
    An Pediatr (Barc); 2012 Feb; 76(2):103.e1-7. PubMed ID: 22075174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.